Loading live market data…

Intensity Therapeutics, Inc.

NASDAQ:INTS

$4.87 USD

-$0.05 (-1.02%)

Volume
53.34K
Average Volume
42.14K
Market Capitalization
$9.18M
P/E Ratio
-0.70
Dividend Yield
0.00%
Price Target
$125.00
Year High
$43.50
Year Low
$3.51
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$4.86

NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)

14

NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)

0

AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)

$ -

INTS Estimated and Actual Revenue by Quarter

Get MSFT Insider Trade Alerts

INTS Insider Trading History

Insider Name Title Date Transaction Cost Filing Date
Wesolowski John M officer: Principal Accounting Officer 2026-06-30 A-Award 3.485 2026-07-01
Talamo Joseph officer: Chief Financial Officer 2026-06-30 A-Award 3.485 2026-07-01
BENDER LEWIS H director, officer: President and CEO 2026-03-26 A-Award 6.11 2026-03-30
Wesolowski John M officer: Principal Accounting Officer 2025-12-31 A-Award 0.262 2026-01-05
Talamo Joseph officer: Chief Financial Officer 2025-12-31 A-Award 0.262 2026-01-05
Wesolowski John M officer: Principal Accounting Officer 2025-06-30 A-Award 0.261 2025-07-02
Talamo Joseph officer: Chief Financial Officer 2025-06-30 A-Award 0.261 2025-07-02
DUBIN THOMAS I H director 2025-05-02 A-Award 0.57 2025-05-06
Donovan Daniel director 2025-05-02 A-Award 0.57 2025-05-06
GOLDBERG MARK A director 2025-05-02 A-Award 0.57 2025-05-06
Leahy Emer director 2025-05-02 A-Award 0.57 2025-05-06
Wesolowski John M officer: Principal Accounting Officer 2025-05-02 A-Award 0.57 2025-05-06
BENDER LEWIS H director, 10 percent owner, officer: President and CEO 2025-05-02 A-Award 0.57 2025-05-06
Talamo Joseph officer: Chief Financial Officer 2025-05-02 A-Award 0.57 2025-05-06
Wesolowski John M officer: Principal Accounting Officer 2024-10-21 A-Award 3.44 2024-10-23
Talamo Joseph officer: Chief Financial Officer 2024-10-21 A-Award 3.44 2024-10-23
Wesolowski John M officer: Principal Accounting Officer 2024-06-05 M-Exempt 4 2024-06-07
Wesolowski John M officer: Principal Accounting Officer 2024-06-05 M-Exempt 4 2024-06-07
DUBIN THOMAS I H director 2024-05-14 A-Award 4.42 2024-05-15
DUBIN THOMAS I H director: 2024-05-14 0 2024-05-15
Wesolowski John M officer: See Remarks 2024-03-06 A-Award 5.19 2024-03-07
Leahy Emer director 2024-03-06 A-Award 5.19 2024-03-07
GOLDBERG MARK A director 2024-03-06 A-Award 5.19 2024-03-07
Donovan Daniel director 2024-03-06 A-Award 5.19 2024-03-07
BENDER LEWIS H director, 10 percent owner, officer: President and CEO 2024-03-06 A-Award 5.19 2024-03-07
BENDER LEWIS H director, 10 percent owner, officer: President and CEO 2024-03-06 A-Award 5.19 2024-03-07
Talamo Joseph officer: Chief Financial Officer 2023-12-11 A-Award 6.88 2023-12-12
Talamo Joseph officer 2023-12-11 0 2023-12-12
Wesolowski John M officer: Interim CFO 2023-07-19 A-Award 6.43 2023-07-21
Wesolowski John M officer: Interim CFO 2023-06-29 0 2023-06-29
Wesolowski John M officer: Interim CFO 2023-06-29 11.5 2023-06-29
Wesolowski John M officer: Interim CFO 2023-06-29 4 2023-06-29
Wesolowski John M officer: Interim CFO 2023-06-29 8 2023-06-29
Wesolowski John M officer: Interim CFO 2023-06-29 9 2023-06-29
BENDER LEWIS H director, 10 percent owner, officer: President and CEO 2023-06-29 0 2023-06-29
BENDER LEWIS H director, 10 percent owner, officer: President and CEO 2023-06-29 11.5 2023-06-29
BENDER LEWIS H director, 10 percent owner, officer: President and CEO 2023-06-29 9 2023-06-29
GOLDBERG MARK A director 2023-06-29 9 2023-06-29
GOLDBERG MARK A director 2023-06-29 11.5 2023-06-29
Leahy Emer director 2023-06-29 11.5 2023-06-29
Leahy Emer director 2023-06-29 9 2023-06-29
Leahy Emer director 2023-06-29 4 2023-06-29
Donovan Daniel director 2023-06-29 9 2023-06-29
Ahlers James M officer: Executive VP of CF 2023-06-29 9 2023-06-29